Residual risk of major adverse cardiovascular and limb events among different atherosclerotic cardiovascular disease phenotypes receiving guideline-recommended antiplatelet monotherapy: The resrisk study. (August 2022)

Record Type:
Journal Article
Title:
Residual risk of major adverse cardiovascular and limb events among different atherosclerotic cardiovascular disease phenotypes receiving guideline-recommended antiplatelet monotherapy: The resrisk study. (August 2022)
Main Title:
Residual risk of major adverse cardiovascular and limb events among different atherosclerotic cardiovascular disease phenotypes receiving guideline-recommended antiplatelet monotherapy: The resrisk study
Authors:
Vallejo-Vaz, A.J.
Dharmayat, K.I.
Nzeakor, N.
Carrasco, C.P.
Fatoba, S.T.
Fonseca, M.J.
Tolani, E.
Lee, C.
Ray, K.K.
Abstract:
Is Part Of:
Atherosclerosis. Volume 355(2022)
Journal:
Atherosclerosis
Issue:
Volume 355(2022)
Issue Display:
Volume 355, Issue 2022 (2022)
Year:
2022
Volume:
355
Issue:
2022
Issue Sort Value:
2022-0355-2022-0000
Page Start:
31
Page End:
Publication Date:
2022-08
Subjects:
Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:
http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.atherosclerosis.2022.06.177 ↗
Languages:
English
ISSNs:
0021-9150
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
23301.xml